Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-activity studies with cytotoxic anthrapyrazoles.

Asher Begleiter1, Denny Lin, Kimberly K Larson

  • 1Manitoba Institute of Cell Biology, CancerCare Manitoba, Departments of Internal Medicine, and Pharmacology and Therapeutics, University of Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba R3E 0V9, Canada. begleit@cc.umanitoba.ca

Oncology Reports
|May 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and characterization of monoclonal antibodies recognizing nucleocapsid protein of multiple SARS-CoV-2 variants.

Heliyon·2024
Same author

Machine-Learning Assisted Screening of Correlated Covariates: Application to Clinical Data of Desipramine.

The AAPS journal·2024
Same author

Duet playing in dementia care: a new therapeutic music technology.

Disability and rehabilitation. Assistive technology·2024
Same author

Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experience.

Headache·2024
Same author

Longitudinal functional outcomes and late effects of radiation following treatment of nasopharyngeal carcinoma: secondary analysis of a prospective cohort study.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2022
Same author

"That was a tip from my physician"-Gender-specific pathways of patients and relatives to outpatient psychosocial cancer counselling centres-A qualitative study.

Psycho-oncology·2022
Same journal

Identification of RRM2 as a key regulator of malignant epithelial cells in gastric cancer through single‑cell transcriptomics.

Oncology reports·2026
Same journal

Impact of WFDC2 on the biological functions of cervical cancer cells and the regulation of the ERK/NF‑κB signaling pathway.

Oncology reports·2026
Same journal

Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer.

Oncology reports·2026
Same journal

Research advances on DKK1 in head and neck squamous cell carcinoma: Linking molecular mechanisms to clinical applications (Review).

Oncology reports·2026
Same journal

PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells.

Oncology reports·2026
Same journal

A fibroblast activation protein degrader enhances cisplatin sensitivity in non‑small cell lung cancer.

Oncology reports·2026
See all related articles

Novel anthrapyrazole compounds show cytotoxic activity against cancer cells by inhibiting DNA topoisomerase II. Structure-activity relationships were explored, revealing key modifications for enhanced efficacy in chemotherapy research.

Area of Science:

  • Medicinal Chemistry
  • Cancer Research
  • Molecular Biology

Background:

  • Anthrapyrazoles are investigated as potential cancer chemotherapeutic agents.
  • Their mechanism of action is linked to the inhibition of DNA topoisomerase II.
  • Understanding structure-activity relationships is crucial for developing effective anticancer drugs.

Purpose of the Study:

  • To synthesize and evaluate the in vitro cytotoxic activity of nine novel anthrapyrazole analogues.
  • To compare the activity of these analogues with clinically tested compounds losoxantrone and piroxantrone.
  • To investigate the role of topoisomerase II inhibition as the mechanism of action for these analogues.

Main Methods:

  • Cytotoxic activity was assessed using the MTT cell growth inhibition assay against human breast carcinoma, head and neck squamous cell carcinoma, leukemia, and Chinese hamster ovary cells.

Related Experiment Videos

  • Inhibition of catalytic topoisomerase II activity was measured via a fluorometric DNA decatenation assay.
  • Structure-activity relationships were analyzed based on modifications in side chains and substituent positions.

    • Main Results:

    • All nine anthrapyrazole analogues exhibited cytotoxic activity against the tested cell lines, with IC50 values ranging from 0.1 to 45.2 microM.
    • Losoxantrone demonstrated the highest potency among the studied analogues.
    • While a tertiary amine in the N-2 side chain generally increased activity, modifications at C-5 and chlorine substituents showed inconsistent effects on cytotoxicity and topoisomerase II inhibition.

    Conclusions:

    • Anthrapyrazole analogues possess significant in vitro cytotoxic potential against various cancer cell lines.
    • The study identified specific structural features influencing cytotoxic activity, though a direct correlation with topoisomerase II inhibition was not consistently observed.
    • Further research into anthrapyrazole derivatives may yield novel anticancer therapeutics.